NIH-funded research R01 grant

Glutathione reductase and neutrophil battles bacteria and fungi

Official title: Glutathione reductase (Gsr) regulates cell metabolism and signaling during neutrophil-pathogen interactions

Funded at Research Inst Nationwide Children's Hosp · NIH-11395628 · Data updated 2026-11-12

This grant studies how neutrophils use a chemical called glutathione to fight infections, which could help improve immune responses in people with bacterial or fungal infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startAugust 18, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$527,960
NIH project number5R01AI193143-02
Project IDNIH-11395628 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with recurrent or difficult-to-treat bacterial or fungal infections or those with blood-related neutrophil concerns who could contribute or benefit from translational studies related to neutrophil metabolism.

Less likely to help

Patients without neutrophil-related immune issues or those not eligible for participation in related translational efforts may see no direct benefit.

What this research studies

Researchers will look at how glutathione reductase affects how neutrophils use metabolism and signaling to kill invading bacteria and fungi. By studying neutrophil metabolism and reactive oxygen species production in mouse models and human cells, they aim to link enzyme activity to immune effectiveness. The work could reveal new angles to boost infection-fighting neutrophil function in patients who struggle to clear infections.

Why it matters

Potential benefit: Finding ways to strengthen neutrophil defense could lead to better therapies for bacterial and fungal infections.

How similar studies have gone: Previous mouse studies show that glutathione reductase influences neutrophil function and infection control, supporting potential translational relevance.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Liu, Yusen — Research Inst Nationwide Children's Hosp
  • Study coordinator: Liu, Yusen

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.